Effects of TGF-β1 on Expression of IL-10 in Immunological Rejection after High-Risk Penetrating Keratoplasty

Huang Xiao
2009-01-01
Abstract:Objective To study the immunosuppressive action of recombinant adeno-associated virus mediated transforming growth factor-β1(rAAV-TGF-β1)on the rat models of high-risk penetrating keratoplasty rejection and the effect of rAAV-TGF-β1 on the expression of interleukin-10(IL-10).Methods The eukaryotic plasmid vector containing rAAV-TGF-β1 was constructed.Forty SD rats were operated with penetrating keratoplasty,and randomly divided into 2 groups:experimental group and control group,20 animals in each group.Corneal neovascularization(CNV)were induced by alkaline cauterization of the central cornea.In experimental group,the donor cornea graft was incubated in 10×1012 v.g·L-1 rAAV-TGF-β1 dulbecco's minimum essential medium mixed culture medium for 30 minutes at 37 ℃,and in control group,the donor graft was treated in phosphate buffered solution for 30 minutes at 37 ℃ before surgery.Mean survival time and rejection index were clinically observed and compared with slit light microscope.The allografts were detected by histopathology,and expression of IL-10 was evaluated by immunhistochemistry at the 1st week,2nd week,4th week and 2nd month postoperatively.Results The mean survival time of control group were(10.40±2.45)d,were(18.70±1.51)d in experimental group,which was statistically significant compared with that of control group(P0.01).Rejection index(RI)of rAAV-TGF-β1 group was markedly lower compared with that of control group(P0.01).The expression of IL-10 were increased at corneal epithelium and endothelium in experimental group compared with those in control group(P0.05).Conclusions Treatment with rAAV-TGF-β1 can significantly prolong the survival time of corneal allograft and suppress the immunological rejection after high-risk penetrating keratoplasty,which may be associated with upregulating the expression of IL-10 in corneas.Recombinant adeno-associated virus is the effective vector for ophthalmological gene therapy.
What problem does this paper attempt to address?